130 related articles for article (PubMed ID: 36945158)
21. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
23. Study on Clinicopathological Features of Gastrointestinal Stromal Tumor and Relevant Prognostic Factors.
Liu Q; Wang Y; Kong L; Kan Y
Cell Biochem Biophys; 2015 Dec; 73(3):743-7. PubMed ID: 27259319
[TBL] [Abstract][Full Text] [Related]
24. Congenital gastrointestinal stromal tumour is morphologically indistinguishable from the adult form, but does not express CD117 and carries a favourable prognosis.
Bates AW; Feakins RM; Scheimberg I
Histopathology; 2000 Oct; 37(4):316-22. PubMed ID: 11012738
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal stromal tumors: A multicenter study of 1160 Turkish cases.
Bülbül Doğusoy G;
Turk J Gastroenterol; 2012 Jun; 23(3):203-11. PubMed ID: 22798108
[TBL] [Abstract][Full Text] [Related]
26. [Succinate dehydrogenase deficient gastrointestinal stromal tumor: a clinicopathologic analysis of eight cases].
Gong Q; Zhang W; Li H; Pan B; Zhang Z
Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):709-13. PubMed ID: 26702527
[TBL] [Abstract][Full Text] [Related]
27. Giant gastrointestinal stromal tumour of rare sarcomatoid epithelioid subtype: case study and literature review.
Lech G; Korcz W; Kowalczyk E; Guzel T; Radoch M; Krasnodębski IW
World J Gastroenterol; 2015 Mar; 21(11):3388-93. PubMed ID: 25805949
[TBL] [Abstract][Full Text] [Related]
28. Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors.
Sahu KK; Tapadia R; Kini JR; Pai RR; Kini H; Nirupama M; Pooja KS
J Cancer Res Ther; 2019; 15(1):138-141. PubMed ID: 30880769
[TBL] [Abstract][Full Text] [Related]
29. Molecular and morphological correlation in gastrointestinal stromal tumours (GISTs): an update and primer.
Chetty R; Serra S
J Clin Pathol; 2016 Sep; 69(9):754-60. PubMed ID: 27317811
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal stromal tumours.
Miettinen M; Sarlomo-Rikala M; Lasota J
Ann Chir Gynaecol; 1998; 87(4):278-81. PubMed ID: 9891765
[TBL] [Abstract][Full Text] [Related]
32. Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors.
Nanding A; Tang L; Cai L; Chen H; Geng J; Liu X; Ning X; Li X; Zhang Q
Gastric Cancer; 2014 Jan; 17(1):87-96. PubMed ID: 23504291
[TBL] [Abstract][Full Text] [Related]
33. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical expression of epidermal growth factor and its prognostic value for gastrointestinal stromal tumors].
Padilla D; Menéndez P; García M; Villarejo P; Cubo T; Gambí D; Pardo R; Martín J
Rev Esp Enferm Dig; 2008 Dec; 100(12):752-7. PubMed ID: 19222333
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
Miettinen M; Sobin LH; Sarlomo-Rikala M
Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
[TBL] [Abstract][Full Text] [Related]
36. [Gastrointestinal stromal tumors].
Ignjatović M
Vojnosanit Pregl; 2002; 59(2):183-202. PubMed ID: 12053473
[TBL] [Abstract][Full Text] [Related]
37. [The role of the DOG1 antibody in the diagnosis of gastrointestinal stromal tumours - GIST].
Gutierrez MR; Dorronsoro ML; Marco AM; Pérez IR; Villegas IA; Virseda JM
An Sist Sanit Navar; 2011; 34(2):245-51. PubMed ID: 21904406
[TBL] [Abstract][Full Text] [Related]
38. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: prognostic implications.
Vassos N; Agaimy A; Hohenberger W; Croner RS
Int J Surg; 2014; 12(5):371-7. PubMed ID: 24632413
[TBL] [Abstract][Full Text] [Related]
39. Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours.
Seidal T; Edvardsson H
Histopathology; 1999 May; 34(5):416-24. PubMed ID: 10231416
[TBL] [Abstract][Full Text] [Related]
40. Ki-67 labelling index is related to the risk classification and prognosis of gastrointestinal stromal tumours: a retrospective study.
Wang JP; Liu L; Li ZA; Wang Q; Wang XY; Lin J
Gastroenterol Hepatol; 2021 Feb; 44(2):103-114. PubMed ID: 32718848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
